×
About 4,500 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  1,187 results

Use of continuous subcutaneous insulin infusion versus multiple daily injections in eme...
https://doi.org/10.1111/imj.15539
Internal Medicine Journal; Chai TYL, Farrell K et. al.

Sep 26th, 2021 - Limited studies have compared outcomes between emerging adults with type 1 diabetes mellitus (T1D) attending a diabetes transition support programme using multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). To asses...

Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Be...
https://doi.org/10.1089/dia.2021.0263
Diabetes Technology & Therapeutics; Frank JR, Blissett D et. al.

Sep 22nd, 2021 - Objective: We assessed the economic impact of using the newest flash continuous glucose monitoring (CGM) among Medicaid beneficiaries with diabetes treated with intensive insulin therapy (IIT). Research Design and Methods: A budget impact analysis...

Enroller Experience and Parental Familiarity of Disease Influence Participation in a Pe...
https://doi.org/10.5811/westjem.2021.4.54647
The Western Journal of Emergency Medicine; Schunk JE, Jacobsen KK et. al.

Sep 22nd, 2021 - Acquiring parental consent is critical to pediatric clinical research, especially in interventional trials. In this study we investigated demographic, clinical, and environmental factors associated with likelihood of parental permission for enroll...

Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Af...
https://doi.org/10.1016/j.transproceed.2021.08.017
Transplantation Proceedings; Cha BM, Davoudi R et. al.

Sep 18th, 2021 - Postoperative euglycemic diabetic ketoacidosis (euDKA) associated with sodium-glucose cotransporter-2 (SGLT2) inhibitor use has been well-documented and carries a Food and Drug Administration recommendation to hold SGLT2 inhibitors 3 to 4 days bef...

Pancreatic β-cell fate in subjects with COVID-19.
https://doi.org/10.1111/jdi.13671
Journal of Diabetes Investigation; Shirakawa J

Sep 17th, 2021 - Subjects with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are still increasing worldwide as of August 2021. The association of COVID-19 with diabetes has been reported in the context...

see more →

Guidelines  5 results

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 17th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Dying well with diabetes.
https://doi.org/10.21037/apm.2018.12.10
Annals of Palliative Medicine; James J

Jan 30th, 2019 - Death is an inevitable part of living. There are undoubtedly clinical and psychological challenges when any individual is passing from life to death. For a person with a long-term condition such as diabetes, these challenges can be compounded and ...

Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS...
https://doi.org/10.1111/dme.13673
Diabetic Medicine : a Journal of the British Diabetic Ass... Price HC, Ismail K et. al.

Aug 29th, 2018 - The Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS) for Inpatient Care guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings are available in full...

see more →

Drugs  349 results see all →

News  259 results

Arkray Recalls SPOTCHEM II Test Strips Due to Inaccurate Blood Sugar Readings [Unpublished] | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/arkray-recalls-spotchem-ii-test-strips-due-inaccurate-blood-sugar-readings-unpublished

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Device SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip Lot...

Patients With Cancer Who Develop Ketoacidosis Fare Badly
https://www.medscape.com/viewarticle/952159

Jun 1st, 2021 - The clinical picture of diabetic ketoacidosis (DKA) differs in several ways among patients with cancer compared to those without cancer, new research indicates.   Traditionally, DKA has been associated with type 1 diabetes, often in younger people...

Most Kids With Type 1 Diabetes and COVID-19 in US Fared Well
https://www.medscape.com/viewarticle/950277

Apr 30th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The majority of children with type 1 diabetes who tested positive for SARS-CoV-2 were cared for at home and did well, according to the first repor...

SGLT2 Inhibitors for T1D? Experts Debate at ENDO 2021
https://www.medscape.com/viewarticle/947963

Mar 26th, 2021 - Full disclosure: SGLT2 inhibitors are not FDA-approved for those with type 1 diabetes (T1D). But with the increased awareness of the benefits of SGLT2 inhibitors in type 2 diabetes (T2D), especially in patients with established cardiovascular and ...

1 in 5 Hospitalized With Diabetic Ketoacidosis Is Readmitted
https://www.medscape.com/viewarticle/947922

Mar 23rd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

see more →